Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
EXAGEN INC. (XGN)
Standardized SEC financial data for EXAGEN INC. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001274737 · NASDAQ · Services-Medical Laboratories.
Gross margin
58.3%
Operating margin
-21.1%
Net margin
-30.0%
Revenue growth (YoY)
19.6%
Return on equity
-114.3%
ROIC
-126.6%
Free cash flow
-$14.3M
Debt / equity
1.35×
Ratios for fiscal year 2025, standardized from SEC filings.